For the Inventor, By the Inventor

Enter assignee name

Takara Bio Inc.

USPTO Granted Patents = 150

% Expired Patents = 64.0

CIPO Patents = 2

EPO Patents = 41

Trademarks = 17

Forward Citations = 488

Loading Chart...

Loading Chart...

237 inventors (with patents filed for the assignee):

Ikunoshin Kato (85 out of 210 patents)

Takashi Uemori (33 out of 44 patents)

Junichi Mineno (29 out of 29 patents)

4. Hiroaki Sagawa (27 out of 45 patents)

5. Kiyozo Asada (22 out of 47 patents)

6. Tatsuji Enoki (21 out of 33 patents)

7. Hiroyuki Mukai (20 out of 29 patents)

8. Hiroshi Shiku (12 out of 24 patents)

9. Hikaru Takakura (12 out of 15 patents)

10. Takeshi Sakai (11 out of 51 patents)

11. Hideto Chono (10 out of 13 patents)

12. Nobuto Koyama (10 out of 37 patents)

13. Eiji Kobayashi (9 out of 36 patents)

14. Yoshimi Sato (9 out of 12 patents)

15. Jun Tomono (9 out of 14 patents)

Core Competencies:

Nucleic Acid

AAV Variant

DNA Polymerase

Stem Cell Production

Chimeric Antigen Receptor

Endonuclease

RNA Detection

Cytotoxic T Lymphocyte

Gene Transfer

Viral Particles

Pluripotent Stem Cells

Nucleic Acid Amplification

150 patents: Sort by Forward Citations

1. 12673097 - IMPROVED DNA VACCINE FOR SARS-COV-2 (2026-07-07),

2. 12606845 - METHOD FOR PRODUCING NUCLEIC ACID-ENCAPSULATED AAV HOLLOW PARTICLE (2026-04-21),

3. 12480132 - HEAT RESISTANT MISMATCH ENDONUCLEASE VARIANT (2025-11-25),

4. 12421526 - AAV mutant having brain-targeting property (2025-09-23),

5. 12359177 - DNA polymerase mutant suited to nucleic acid amplification from RNA (2025-07-15),

6. 12018294 - DNA polymerase mutant suited to nucleic acid amplification from RNA (2024-06-25),

7. 12018276 - Lymphocyte production method (2024-06-25),

8. 11999972 - Fibronectin fragment to be used for stem cell production (2024-06-04),

9. 11572580 - Oligonucleotide preservation method (2023-02-07),

10. 11473057 - Method for obtaining microglia from pluripotent stem cells (2022-10-18),

11. 11225643 - Method for producing endothelial cells (2022-01-18),

12. 11220677 - Heat-resistant reverse transcriptase mutant (2022-01-11),

13. 11046939 - DNA polymerase variant (2021-06-29),

14. 11028131 - Mutant of adeno-associated virus (AAV) capsid protein (2021-06-08),

15. 10975415 - Methods of utilizing thermostable mismatch endonuclease (2021-04-13),

TAKARA BIO INC. is a leading biotechnology company specializing in the development and commercialization of innovative tools and technologies for life science research and healthcare. With a wide range of products and services, we strive to support scientists and healthcare professionals worldwide in their quest for new discoveries and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

150 Patents

#3 in Shiga

#855 in Japan

#5,428 in the World

Takara Bio Inc.

Forward Citations = 488

237 inventors:

Ikunoshin Kato (85 out of 210 patents)

Takashi Uemori (33 out of 44 patents)

Junichi Mineno (29 out of 29 patents)

4. Hiroaki Sagawa (27 out of 45 patents)

5. Kiyozo Asada (22 out of 47 patents)

Please report any incorrect information to [email protected]

Loading…